TY - JOUR
T1 - Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta
AU - Stephen, Joshi
AU - Shukla, Anju
AU - Dalal, Ashwin
AU - Girisha, Katta Mohan
AU - Shah, Hitesh
AU - Gupta, Neerja
AU - Kabra, Madhulika
AU - Dabadghao, Preeti
AU - Phadke, Shubha R.
PY - 2014
Y1 - 2014
N2 - Osteogenesis imperfecta (OI) is a condition of decreased bone density with heterogeneous etiologies. Most of the cases are inherited in an autosomal dominant fashion and are caused by mutations in the COL1A1 or COL1A2 genes. Since these two genes are very large, there are no data about mutations in Indian patients with OI. We selected 35 Indian patients who were clinically diagnosed with OI and all exons of both the genes were sequenced. Mutations in COL1A1 (14 cases, 6 novel) and COL1A2 (11 cases, 7 novel) were identified in 25 patients. A total of 55 polymorphisms were identified in both the genes with eight novel variants in the coding region, and nine novel variants in the non-coding regions. No mutation was detected in 10 patients. Six of them were from consanguineous families, with one or two similarly affected siblings suggesting possible autosomal recessive inheritance. If we exclude families with consanguinity, mutations were identified in 25 out of 29 families giving 86% mutation detection rate. Mutations in COL1A1 accounted for 56% of the cases and COL1A2 44%, which is similar to the reported rate worldwide.
AB - Osteogenesis imperfecta (OI) is a condition of decreased bone density with heterogeneous etiologies. Most of the cases are inherited in an autosomal dominant fashion and are caused by mutations in the COL1A1 or COL1A2 genes. Since these two genes are very large, there are no data about mutations in Indian patients with OI. We selected 35 Indian patients who were clinically diagnosed with OI and all exons of both the genes were sequenced. Mutations in COL1A1 (14 cases, 6 novel) and COL1A2 (11 cases, 7 novel) were identified in 25 patients. A total of 55 polymorphisms were identified in both the genes with eight novel variants in the coding region, and nine novel variants in the non-coding regions. No mutation was detected in 10 patients. Six of them were from consanguineous families, with one or two similarly affected siblings suggesting possible autosomal recessive inheritance. If we exclude families with consanguinity, mutations were identified in 25 out of 29 families giving 86% mutation detection rate. Mutations in COL1A1 accounted for 56% of the cases and COL1A2 44%, which is similar to the reported rate worldwide.
UR - http://www.scopus.com/inward/record.url?scp=84899990638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899990638&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.36481
DO - 10.1002/ajmg.a.36481
M3 - Article
C2 - 24668929
AN - SCOPUS:84899990638
SN - 1552-4825
VL - 164
SP - 1482
EP - 1489
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 6
ER -